Review: The spectrum of clinical features seen with alpha synuclein pathology

Pathological Interface Between Oligomeric Alpha-Synuclein and Tau in Synucleinopathies

(2015) Urmi Sengupta et al.   BIOLOGICAL PSYCHIATRY

When DLB, PD, and PSP masquerade as MSA

(2015) Shunsuke Koga et al.   NEUROLOGY

Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly

(2015) Julia Zaccai et al.   Alzheimers Research & Therapy

Glucocerebrosidase is shaking up the synucleinopathies

(2014) Marina Siebert et al.   BRAIN

Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson’s disease and other Lewy body disorders

(2014) Veronica Lindström et al.   Immunotherapy

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

(2014) H.-F. Wang et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Clinical spectrum of impulse control disorders in Parkinson's disease

(2014) Daniel Weintraub et al.   MOVEMENT DISORDERS

GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study

(2014) Kathrin Brockmann et al.   MOVEMENT DISORDERS

Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders

(2014) Ellen Gelpi et al.   MOVEMENT DISORDERS

Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study

(2014) D. Jennings et al.   NEUROLOGY

Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status

(2014) Sarah E. Monsell et al.   PARKINSONISM & RELATED DISORDERS

Comparing clinical features of young onset, middle onset and late onset Parkinson's disease

(2014) Raja Mehanna et al.   PARKINSONISM & RELATED DISORDERS

Sleep and Circadian Rhythm Regulation in Early Parkinson Disease

(2014) David P. Breen et al.   JAMA Neurology

Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort

(2013) Sophie E. Winder-Rhodes et al.   BRAIN

A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type

(2013) C. Siri et al.   JOURNAL OF NEURAL TRANSMISSION

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results

(2013) A. J. Noyce et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

(2013) Caroline H Williams-Gray et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study

(2013) Alex Iranzo et al.   LANCET NEUROLOGY

Characterizing mild cognitive impairment in incident Parkinson disease: The ICICLE-PD Study

(2013) A. J. Yarnall et al.   NEUROLOGY

Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in North East Scotland: The PINE study

(2013) Robert Caslake et al.   PARKINSONISM & RELATED DISORDERS

Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series

(2013) Carlos H. Schenck et al.   SLEEP MEDICINE

The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson’s disease: a PET study

(2012) Kit Wu et al.   BRAIN

Sleep-Disordered Breathing in Neurodegenerative Diseases

(2012) Carles Gaig et al.   Current Neurology and Neuroscience Reports

Prevalence of Blepharospasm and Apraxia of Eyelid Opening in Patients with Parkinsonism, Cervical Dystonia and Essential Tremor

(2012) Abdul-Qayyum Rana et al.   EUROPEAN NEUROLOGY

The link between the GBA gene and parkinsonism

(2012) Ellen Sidransky et al.   LANCET NEUROLOGY

Brain amyloid and cognition in Lewy body diseases

(2012) Stephen N. Gomperts et al.   MOVEMENT DISORDERS

Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases

(2012) Kathleen M. Shannon et al.   MOVEMENT DISORDERS

Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: A prospective study

(2012) Ronald B. Postuma et al.   MOVEMENT DISORDERS

APOE ϵ4 Increases Risk for Dementia in Pure Synucleinopathies

(2012) Debby Tsuang et al.   JAMA Neurology

Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population-based study

(2011) Brendon P. Boot et al.   ANNALS OF NEUROLOGY

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

(2011) Y. Compta et al.   BRAIN

The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration

(2011) J. L. Cummings et al.   BRAIN

Depression and anxiety related subtypes in Parkinson's disease

(2011) R. G. Brown et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The natural history of treated Parkinson's disease in an incident, community based cohort

(2011) J. R. Evans et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome

(2011) Sophie E. Winder-Rhodes et al.   MOVEMENT DISORDERS

Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease

(2011) Bart Post et al.   MOVEMENT DISORDERS

Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross-sectional study

(2011) Albert F. G. Leentjens et al.   MOVEMENT DISORDERS

Depression in Parkinson disease—epidemiology, mechanisms and management

(2011) Dag Aarsland et al.   Nature Reviews Neurology

Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy

(2011) Nahuai Badiola et al.   PLoS One

Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population-based study

(2010) Jan Linder et al.   MOVEMENT DISORDERS

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

(2009) Caroline H. Williams-Gray et al.   BRAIN

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

(2009) Juliane Neumann et al.   BRAIN

Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease

(2009) C. H. Williams-Gray et al.   JOURNAL OF NEUROLOGY

Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study

(2009) G Alves et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

(2009) E. Sidransky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography

(2008) P Edison et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?

(2008) Christopher H. Hawkes   MOVEMENT DISORDERS

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

(2008) R. B. Postuma et al.   NEUROLOGY

Second consensus statement on the diagnosis of multiple system atrophy

(2008) S. Gilman et al.   NEUROLOGY